A review. On page 170, paragraph 1, line 3 should read: "P2Y 12 is the target of efficacious antithrombotic agents like ticlopidine and clopidogrel which are already used in clinical practice, and the AR-C compounds, one of which is currently under evaluation in clinical trials.".
The P2 receptors and congenital platelet function defects: Erratum to document cited in CA143:403250 / M. Cattaneo. - In: SEMINARS IN THROMBOSIS AND HEMOSTASIS. - ISSN 0094-6176. - 32:1(2006), pp. 77-78. [10.1055/s-2006-933343]
The P2 receptors and congenital platelet function defects: Erratum to document cited in CA143:403250
M. CattaneoPrimo
2006
Abstract
A review. On page 170, paragraph 1, line 3 should read: "P2Y 12 is the target of efficacious antithrombotic agents like ticlopidine and clopidogrel which are already used in clinical practice, and the AR-C compounds, one of which is currently under evaluation in clinical trials.".File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.